ORTEXORTEX News
Tracking EVR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EV
Trader NoteEVR

Evercore Shorts Retreat as Analysts Mark Down Targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 19:33

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

EVR is heading into a post-earnings week with short sellers clearly less convinced of the bear case, even as the Street's price targets sit well above where the stock is trading.

Short interest has fallen sharply and is not the story here. Bears cut positions by roughly 14% over the past week, leaving short interest at just 2.7% of the free float, a level that was already sliding through October from around 3.3% in mid-month. Borrow costs remain negligible at 0.43%, and availability is extraordinarily loose, with shares available to borrow running at nearly 67 times existing short interest. There is no short squeeze dynamic, no borrow squeeze, and no sign that the remaining shorts face any pressure. The retreat looks orderly rather than forced.

Options positioning tells a somewhat different story, and that contrast is worth sitting with. The put/call ratio has climbed to 0.63, a full standard deviation above its 20-day average of 0.48, and it has been trending higher throughout the month. Back in late September the ratio was below 0.27, near the year's low. The shift is not dramatic enough to call it a fear signal, but it does mark a clear change in sentiment since the start of October, with traders buying proportionally more downside protection than they were a month ago. Earnings reported today may resolve some of that hedging.

The Street broadly remains cautious, though there is meaningful disagreement about the ceiling. The consensus sits at hold, with five analysts there and just one outperform. Morgan Stanley lowered its target to $315 from $363 on October 8, and UBS cut to $318 from $359 the day before. Goldman Sachs, the sole bull, also trimmed its target to $331 from $377 at the start of the month. All three maintained their existing ratings, a reminder that this round of cuts reflected macro and sector-level adjustments rather than firm-specific downgrades. The mean target across the group is $332.90, implying roughly 28% above the current price of $259.86. That gap is notable, though a portion of it may reflect how far the stock has sold off rather than genuine upside conviction. The bull case rests on M&A pipeline momentum and a 23% year-over-year jump in advisory revenues that crushed consensus, while the bear argument focuses on margin pressure, with the compensation ratio being trimmed in guidance and advisory fee dependency in an uncertain deal environment.

On valuation, the trailing price/earnings multiple is running at 12.8, while price/book is 4.1. Neither has moved much over the past week. The earnings yield factor sits in the 64th percentile, and the analyst recommendation divergence score is in the 91st percentile, reflecting how wide the gap between the hold consensus and the stock's upside implied by targets has become. EPS momentum scores are soft, ranking in the low teens on the 90-day window, suggesting revisions have been heading in the wrong direction even as the actual results have surprised.

One filing worth noting: Edward Hyman, the well-known economic forecaster and a significant shareholder, last disclosed a 13D/A position of 4.3% of the class in February 2025. That is an activist-type filing, though no public campaign has been announced and his position now appears to have slipped below 5% per the institutional data. As always with 13D/G disclosures, the stake reflects the last filing date around the 5% threshold, and a holder dropping below that level is not required to file again.

Wikipedia page views for Evercore are running with a z-score of 1.77 against the prior 90 days, suggesting retail attention is above its recent norm. That kind of traffic uptick often follows a results announcement and is worth watching to see whether it fades quickly or sustains. The next scheduled earnings event is February 3, 2027, so the immediate catalyst has now passed and the focus shifts to how management commentary on deal pipelines and year-end fee recognition shapes the narrative heading into Q4.

Stocks in this article

See the live data behind this article on ORTEX.

Open EVR on ORTEX →

How this article was generated

Generated
28 Oct 2026, 19:35
Data as of
28 Oct 2026, 19:33
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.